Skiest, Daniel J <br/><br/>
Similar efficacy of raltegravir when used with or without a protease inhibitor in treatment-experienced patients.  [electronic resource] 

 -  HIV clinical trials   
 - 131-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-4336 
<br/><br/><label>Standard No.: </label>10.1310/hct1203-131  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CD4 Lymphocyte Count<br/>Drug Therapy, Combination<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Integrase Inhibitors--therapeutic use<br/>HIV Protease Inhibitors--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Pyrrolidinones--administration & dosage<br/>RNA, Viral--analysis<br/>Raltegravir Potassium